Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This investigational topical treatment consists of eyelid swabs (wipes) impregnated with tea tree oil (TTO) and chamomile oil. Developed by researchers at Istanbul University-Cerrahpasa in collaboration with Koç University, it is primarily evaluated for the treatment of seborrheic blepharitis. The formulation leverages the antimicrobial and anti-parasitic properties of tea tree oil—specifically targeting *Demodex* mites often associated with blepharitis—and the anti-inflammatory and soothing properties of chamomile oil. In a double-blind randomized clinical trial (NCT04678531), the swabs demonstrated efficacy in reducing symptoms and clinical signs of blepharitis compared to baby shampoo, showing potential for superior symptomatic improvement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tea tree oil + chamomile oil lid swabs.